The development of a new drug product from a previously approved drug substance has been widely and actively pursued as a cost-effective approach (relative to the development of a new drug entity) to address unmet medical needs. On this front, Chula4DR aims to facilitate advancement of the new drug product development from laboratory to registration by working in collaboration with local pharmaceutical industries and/or research institutions, as well as Thai FDA.